Enhancing the Functional Maturity of Induced Pluripotent Stem Cell-Derived Human Hepatocytes by Controlled Presentation of Cell-Cell Interactions In Vitro

被引:158
作者
Berger, Dustin R. [1 ]
Ware, Brenton R. [1 ]
Davidson, Matthew D. [1 ]
Allsup, Samuel R. [1 ,2 ]
Khetani, Salman R. [1 ,2 ]
机构
[1] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA
基金
美国国家科学基金会;
关键词
INDUCED LIVER-INJURY; MICROPATTERNED COCULTURES; NONPARENCHYMAL CELLS; HUMAN FIBROBLASTS; DRUG DEVELOPMENT; RAT HEPATOCYTES; GENERATION; CULTURE; DIFFERENTIATION; TRANSCRIPTION;
D O I
10.1002/hep.27621
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Induced pluripotent stem cell-derived human hepatocyte-like cells (iHeps) could provide a powerful tool for studying the mechanisms underlying human liver development and disease, testing the efficacy and safety of pharmaceuticals across different patients (i.e., personalized medicine), and enabling cell-based therapies in the clinic. However, current in vitro protocols that rely upon growth factors and extracellular matrices (ECMs) alone yield iHeps with low levels of liver functions relative to adult primary human hepatocytes (PHHs). Moreover, these low hepatic functions in iHeps are difficult to maintain for prolonged times (weeks to months) in culture. Here, we engineered a micropatterned coculture (iMPCC) platform in a multiwell format that, in contrast to conventional confluent cultures, significantly enhanced the functional maturation and longevity of iHeps in culture for at least 4 weeks in vitro when benchmarked against multiple donors of PHHs. In particular, iHeps were micropatterned onto collagen-coated domains of empirically optimized dimensions, surrounded by 3T3-J2 murine embryonic fibroblasts, and then sandwiched with a thin layer of ECM gel (Matrigel). We assessed iHep maturity by global gene expression profiles, hepatic polarity, secretion of albumin and urea, basal cytochrome P450 (CYP450) activities, phase II conjugation, drug-mediated CYP450 induction, and drug-induced hepatotoxicity. Conclusion: Controlling both homotypic interactions between iHeps and heterotypic interactions with stromal fibroblasts significantly matures iHep functions and maintains them for several weeks in culture. In the future, iMPCCs could prove useful for drug screening, studying molecular mechanisms underlying iHep differentiation, modeling liver diseases, and integration into human-on-a-chip systems being designed to assess multiorgan responses to compounds. (Hepatology 2015;61:1370-1381)
引用
收藏
页码:1370 / 1381
页数:12
相关论文
共 40 条
[1]
Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening [J].
Baxter, Melissa A. ;
Rowe, Cliff ;
Alder, Jane ;
Harrison, Sean ;
Hanley, Karen Piper ;
Park, B. Kevin ;
Kitteringham, Neil R. ;
Goldring, Chris E. ;
Hanley, Neil A. .
STEM CELL RESEARCH, 2010, 5 (01) :4-22
[2]
Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells [J].
Bhatia, SN ;
Balis, UJ ;
Yarmush, ML ;
Toner, M .
FASEB JOURNAL, 1999, 13 (14) :1883-1900
[3]
CellNet: Network Biology Applied to Stem Cell Engineering [J].
Cahan, Patrick ;
Li, Hu ;
Morris, Samantha A. ;
da Rocha, Edroaldo Lummertz ;
Daley, George Q. ;
Collins, James J. .
CELL, 2014, 158 (04) :903-915
[4]
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol [J].
Chen, Yu-Fan ;
Tseng, Chien-Yu ;
Wang, Hsei-Wei ;
Kuo, Hung-Chih ;
Yang, Vincent W. ;
Lee, Oscar K. .
HEPATOLOGY, 2012, 55 (04) :1193-1203
[5]
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming [J].
Du, Yuanyuan ;
Wang, Jinlin ;
Jia, Jun ;
Song, Nan ;
Xiang, Chengang ;
Xu, Jun ;
Hou, Zhiyuan ;
Su, Xiaohua ;
Liu, Bei ;
Jiang, Tao ;
Zhao, Dongxin ;
Sun, Yingli ;
Shu, Jian ;
Guo, Qingliang ;
Yin, Ming ;
Sun, Da ;
Lu, Shichun ;
Shi, Yan ;
Deng, Hongkui .
CELL STEM CELL, 2014, 14 (03) :394-403
[6]
Integrating Human Pluripotent Stem Cells into Drug Development [J].
Engle, Sandra J. ;
Puppala, Dinesh .
CELL STEM CELL, 2013, 12 (06) :669-677
[7]
Human Induced Pluripotent Stem Cells in Hepatology Beyond the Proof of Concept [J].
Gerbal-Chaloin, Sabine ;
Funakoshi, Natalie ;
Caillaud, Amandine ;
Gondeau, Claire ;
Champon, Benoite ;
Si-Tayeb, Karim .
AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (02) :332-347
[8]
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins [J].
Gerets, H. H. J. ;
Tilmant, K. ;
Gerin, B. ;
Chanteux, H. ;
Depelchin, B. O. ;
Dhalluin, S. ;
Atienzar, F. A. .
CELL BIOLOGY AND TOXICOLOGY, 2012, 28 (02) :69-87
[9]
Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture [J].
Gieseck, Richard L., III ;
Hannan, Nicholas R. F. ;
Bort, Roque ;
Hanley, Neil A. ;
Drake, Rosemary A. L. ;
Cameron, Grant W. W. ;
Wynn, Thomas A. ;
Vallier, Ludovic .
PLOS ONE, 2014, 9 (01)
[10]
Transcription factors controlling responses to toxic chemicals [J].
Godoy, P. ;
Reif, R. .
ARCHIVES OF TOXICOLOGY, 2013, 87 (01) :3-4